Zomig Instant-2,5 2,5 mg compr. disp. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zomig instant-2,5 2,5 mg compr. disp.

grunenthal sa-nv - zolmitriptan 2,5 mg - comprimé dispersible - 2,5 mg - zolmitriptan 2.5 mg - zolmitriptan

Zomig Instant-5 5 mg compr. orodisp. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zomig instant-5 5 mg compr. orodisp.

grunenthal sa-nv - zolmitriptan 5 mg - comprimé orodispersible - 5 mg - zolmitriptan 5 mg - zolmitriptan

Zomig Nasal-2,5 2.5 mg/dose sol. pulv. nas. flac. pulv. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zomig nasal-2,5 2.5 mg/dose sol. pulv. nas. flac. pulv.

grunenthal sa-nv - zolmitriptan 2,5 mg/0,1 ml - solution pour pulvérisation nasale - 2,5 mg/dose - zolmitriptan 2.5 mg/dose - zolmitriptan

Zomig Nasal-5 5 mg/dose sol. pulv. nas. flac. pulv. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zomig nasal-5 5 mg/dose sol. pulv. nas. flac. pulv.

grunenthal sa-nv - zolmitriptan 5 mg/0,1 ml - solution pour pulvérisation nasale - 5 mg/dose - zolmitriptan 5 mg/dose - zolmitriptan

Zomig Oral 2,5 2.5 mg compr. pellic. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zomig oral 2,5 2.5 mg compr. pellic.

grunenthal sa-nv - zolmitriptan 2,5 mg - comprimé pelliculé - 2,5 mg - zolmitriptan 2.5 mg - zolmitriptan

Zomig Oral 5 5 mg comp. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zomig oral 5 5 mg comp.

grunenthal sa-nv - zolmitriptan 5 mg - comprimé - 5 mg - zolmitriptan 5 mg - zolmitriptan

Zomig Nasal Spray New Zealand - engelsk - Medsafe (Medicines Safety Authority)

zomig nasal spray

astrazeneca limited - zolmitriptan 5mg - nasal spray solution - 5 mg - active: zolmitriptan 5mg excipient: citric acid dibasic sodium phosphate dihydrate purified water

Zomig Nasal Spray New Zealand - engelsk - Medsafe (Medicines Safety Authority)

zomig nasal spray

astrazeneca limited - zolmitriptan 50 mg/ml - nasal spray solution - 5 mg/dose - active: zolmitriptan 50 mg/ml excipient: citric acid dibasic sodium phosphate dihydrate purified water

ZOMIG 2.5 MG Israel - engelsk - Ministry of Health

zomig 2.5 mg

astrazeneca (israel) ltd - zolmitriptan - film coated tablets - zolmitriptan 2.5 mg - zolmitriptan - zolmitriptan - acute treatment of migraine with or without aura.

ZOMIG- zolmitriptan tablet USA - engelsk - NLM (National Library of Medicine)

zomig- zolmitriptan tablet

dispensing solutions, inc. - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan 5 mg - zomig is indicated for the acute treatment of migraine with or without aura in adults. zomig should only be used where a clear diagnosis of migraine has been established. zomig is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see contraindications). safety and effectiveness of zomig have not been established for cluster headache, which is present in an older, predominantly male population. zomig should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm, including prinzmetal’s variant angina, or other significant underlying cardiovascular disease (see warnings and precautions). zomig should not be given to patients with cerebrovascular syndromes including (but not limited to) stroke of any type as well as transient ischemic attacks (see warnings